Quality Assurance Through Evidence, Clarity and Care

Quality assurance starts with understanding how products are manufactured, examining supporting documentation and keeping conclusions within what the available evidence supports. Our approach combines firsthand supplier assessment with scientific review and clear communication.

Firsthand supplier assessment

We have visited and audited our supplier's manufacturing facility as part of our supplier quality assessment. This provides firsthand insight into the facility's operations and informs our review of supporting documentation.

The facility holds ISO 22716 certification for cosmetic good manufacturing practices and a separate pharmaceutical GMP certification. We assess each credential within its stated scope, including the manufacturing activities and products covered. These credentials form part of our supplier assessment, alongside product specifications, batch documentation and available analytical results.

Supplier assessment and batch-specific evidence remain complementary parts of our review.

Expertise behind our quality process

TAM Global's Quality Assurance and Product Specialist is a Registered Chemist with experience in pharmaceutical manufacturing, quality assurance and regulatory affairs. She has also successfully completed the CQI and IRCA ISO 9001:2015 Lead Auditor examination.

Her role combines quality-focused document assessment, scientific content review and technical product consultation.

What we review

A quality review begins by identifying the claim being made and the evidence needed to support it. Depending on the product and available documentation, our review considers:

• Supplier documentation and the scope of relevant certifications.
• Product specifications and Certificates of Analysis (COAs).
• Batch and lot identification.
• Manufacturing dates and expiry or retest information.
• Analytical methods and reported results.
• Gaps, inconsistencies or information requiring clarification.

A COA is assessed in relation to the batch it identifies, the methods reported and the characteristics tested. Conclusions are limited to what that documentation supports. Where information is incomplete or unclear, it is identified for further verification rather than presented as established fact.

Clear scientific communication

Our specialist also reviews scientific website content for accuracy, alignment with source material and appropriate interpretation.

This includes distinguishing research findings from established conclusions and checking whether product claims extend beyond the available evidence.

Peptide product consultation

Understanding product documentation can raise technical questions. Our Quality Assurance and Product Specialist is available by appointment to help explain:

• Peptide product specifications.
• COAs and reported analytical results.
• Batch documentation and traceability information.
• Relevant scientific literature and its limitations.
• Research-use considerations and questions requiring further verification.

Consultations focus on technical product information. They do not include medical advice, diagnosis, treatment recommendations, dosing or guidance on personal administration.

Evidence before assumption

For TAM Global, quality assurance means combining firsthand assessment with careful review and communicating clearly about what is supported, what remains uncertain and what still needs to be verified.